The default first-time KSM-66 buyer pick — trial-dose-exact, patent-verified, public per-batch COA.
Double Wood KSM-66 Ashwagandha is the bottle to buy if you're shopping ashwagandha for the first time. The trial-dose match is the differentiator — 600 mg/day of Ixoreal-licensed KSM-66 — a two-capsule serving, 300 mg each — is the exact dose Wankhede 2015 used to measure +96 ng/dL testosterone vs +18 placebo, and the exact dose Lopresti 2019 used to measure +14.7% total T and +18% DHEA-S in overweight men 40-70. The serving size is the clinical dose: two caps with breakfast and you're at the trial-grade 600 mg/day, at $22/month — verified by a public per-batch COA, not just a label number.
The Ixoreal patent is verified, the COA is public per batch, and the price doesn't make the math hard. Eight weeks on the protocol, here's the full breakdown.
Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Ashwagandha guide →KSM-66 by Ixoreal Biomed, 5% withanolides root-only full-spectrum extract. The standard KSM-66 specification — the form measured in all 24+ published KSM-66 RCTs including Wankhede 2015 and Lopresti 2019. Ixoreal patent logo verified on the bottle back panel; this isn't a relabelled generic, it's contractually fully-reacted standardised extract. Loses 1 point only because 10% withanolide UHP (Toniiq) is theoretically more concentrated — but that concentration isn't what the trials used.
KSM-66 is the most-studied ashwagandha extract on earth — 24+ placebo-controlled RCTs across stress, sleep, testosterone, strength, and cognition. Wankhede 2015 (PMID 26609282) and Lopresti 2019 testosterone (PMID 31517876) both used exactly this extract at exactly this dose. Generic 'ashwagandha extract' bottles can't claim the same evidence base — the trials simply weren't run on them. Loses 0.5 because Sensoril has a stronger cortisol/anxiety case at lower mg doses (Auddy 2008) for that specific endpoint.
Public per-batch Certificate of Analysis — Double Wood publishes COAs on their website with lot-lookup, showing withanolide percentage, heavy metals (lead/cadmium/mercury/arsenic), and microbial assays. GMP-certified facility. Loses 1 point only because Double Wood isn't NSF-registered (Toniiq is) — the per-batch COA does the same documentation job, but NSF facility audits add an extra layer that maxxers value.
600 mg per serving (two 300 mg capsules) — the EXACT daily dose used in Wankhede 2015 (testosterone +96 ng/dL), Lopresti 2019 testosterone (+14.7% total T), and Chandrasekhar 2012 (-27.9% cortisol). Double Wood's labeled serving IS one day's clinical dose, so there's no scaling math — take the two-cap serving and you're on the trial dose, with a per-batch COA to verify the withanolides behind it. Perfect mark because the serving lands exactly on the trial dose and the documentation backs it; Toniiq runs 1300 mg/cap above the trial window, and the non-standardised bottles can't anchor a real dose at all.
$22/month for the 600 mg/day trial dose (a two-capsule serving) = ~$0.012 per mg active withanolide (5% of 600 mg = 30 mg withanolides/day). Middle of the field — Nutricost KSM-66 hits the same dose at $14/month ($0.008/mg active), Toniiq UHP hits a higher concentration at $32 ($0.011/mg active). Fair price for the public COA + Ixoreal verification + Amazon track record, but not the cheapest legitimate KSM-66 available.
“Made with KSM-66 — the most studied form of ashwagandha.”
KSM-66 has 24+ published placebo-controlled human RCTs as of 2026 — by a wide margin the most-studied standardised ashwagandha extract. The Ixoreal patent logo on the bottle is verifiable; Double Wood is on Ixoreal's published authorised buyers list. The 'most studied form' claim is literal truth.
“600 mg per capsule — the clinical dose for stress and testosterone support.”
600 mg/day is the exact dose used in Wankhede 2015 (PMID 26609282), Lopresti 2019 testosterone (PMID 31517876), and Chandrasekhar 2012 (PMID 23439798). The 'clinical dose' framing is accurate to the published trial literature. Few competitor bottles can substantiate this claim with the same specificity.
“Supports natural testosterone levels.”
Verified in stressed, overweight, or resistance-trained populations — Lopresti 2019 measured +14.7% total T at 600 mg/8 weeks in men 40-70; Wankhede 2015 measured +96 ng/dL in resistance-trained men. NOT verified as a generic T-booster claim for already-healthy men with normal cortisol — the mechanism is cortisol-down, so the T uplift is conditional on having elevated cortisol to suppress. Real claim for the right population.
“Promotes relaxation and helps reduce stress.”
Chandrasekhar 2012 measured -44% perceived stress and -27.9% morning cortisol at exactly 600 mg/day KSM-66 over 60 days in chronically stressed adults. The relaxation/stress claim is the most well-established KSM-66 effect — it's the headline mechanism, not a side-claim.
“Third-party tested and made in a GMP-certified facility.”
Per-batch COAs are publicly published on Double Wood's website with lot-lookup. GMP certification of the contract facility is verifiable. The COA documentation discipline is above the Nutricost / generic tier and approaches (without quite matching) the clinical-channel tier of brands like Pure Encapsulations or Life Extension.
The reason to reach for Double Wood isn't cap-count — it's that the labeled serving IS the trial dose, with a public COA to back it. Two 300 mg capsules deliver exactly the 600 mg/day Wankhede 2015 and Lopresti 2019 used, so there's no scaling math to get wrong, and the per-batch Certificate of Analysis lets you confirm the withanolide content of your specific bottle. For first-time buyers, that combination — a serving that equals the clinical dose plus lot-level verification — is the highest-leverage feature on the bottle, far more than any difference in how many capsules you swallow.
Counterfeit KSM-66 is the #1 ashwagandha adulteration vector on Amazon — bottles that print 'KSM-66' on the label but ship 1-2% withanolide generic root powder. Ixoreal Biomed publishes an authorised buyers list, and Double Wood is on it; the bottle carries the official KSM-66 logo on the back panel. If you can't see that logo or verify the brand on Ixoreal's site, you're holding a counterfeit. This is the cheapest fraud-protection step in the supplement world and 80% of buyers skip it.
Nutricost KSM-66 ships the same dose at the same standardisation for $14/month — but their COAs are internal-only, available on request. Double Wood publishes per-batch COAs publicly with lot-lookup, so you can verify YOUR bottle's specific batch shows the declared 5% withanolides. For audit-driven users (athletes worried about drug testing, anyone running multi-supplement protocols and tracking responder data, anyone burned by past counterfeit experiences), per-batch visibility is the documented QC layer that justifies paying $8/month more than the budget tier.
Because Double Wood now ships 300 mg per capsule (two per serving), it covers both dosing patterns from one bottle. Want the Wankhede 2015 morning-only protocol? Take both caps with breakfast for the full 600 mg AM. Want the dual cortisol-lowering + sleep-deepening effect? Split one cap AM and one PM — 300 mg in each window — exactly like the Lopresti 2019 split protocol, no second product required. The 300 mg granularity also lets sensitive responders start at a single 300 mg cap and ramp to 600 mg. Most first-time buyers will just take both caps in the morning; stack-builders and cautious starters get the flexibility for free.
Ashwagandha suppresses HPA-axis cortisol; tongkat ali (LJ100 specifically) displaces SHBG, liberating bound testosterone. Different mechanisms, additive outcomes. The cleanest stack at the trusted-brand tier: Double Wood KSM-66 600 mg AM + Double Wood LJ100 Tongkat 200 mg AM. Two bottles, ~$45/month total. Stress-crashed lifters running both report ~50-100 ng/dL more free T uplift over 8 weeks than from doubling either alone. Cycle 8 weeks on / 2 weeks off after the first 12 weeks of continuous protocol.
Double Wood KSM-66 is what we recommend to anyone shopping their first ashwagandha bottle for the testosterone endpoint. It clears every meaningful bar: real Ixoreal-licensed KSM-66 (verified patent, not counterfeit), 600 mg per 2-capsule serving landing exactly on the Wankhede 2015 / Lopresti 2019 trial dose, public per-batch COA with lot-lookup, and $22/month that doesn't make the math hard. The highest-leverage feature is that the labeled serving equals the trial dose, backed by a public COA — so you can't accidentally under-dose and you can verify your bottle's actives. Take the two-capsule serving (600 mg) with breakfast for 8 weeks. Re-test cortisol, free T, DHEA-S, and SHBG. Decide from numbers, not vibes. The real reason this bottle wins the 'Best Overall' badge is the absence of any disqualifying flaw. Toniiq UHP has higher per-cap potency but costs 45% more; Nutricost matches the dose but skips the public COA; Jarrow ships the same 300 mg/cap form from a 47-year brand but without the public COA and at a higher per-active-mg cost; Life Extension Sensoril runs a different patent with weaker testosterone evidence. Double Wood has no asterisk for the first-time KSM-66 buyer. The patent is real, the dose is trial-exact, the QC documentation is public, the price is competitive. Buy it. Upgrade triggers: after the 8-week baseline, if you respond well and want to push potency, move to Toniiq UHP for cycle two. If you respond well and want to save money, move to Nutricost KSM-66 for cycle two. If you didn't respond, stack with tongkat ali (Double Wood LJ100) or re-evaluate whether your cortisol was actually elevated baseline — KSM-66 is a cortisol-down lever, not a T-up lever.
The premium upgrade at $32/month — 10% withanolide UHP, Toniiq's own 20:1 extract (2× the standardisation of standard KSM-66, not a KSM-66 itself), NSF-grade facility. Worth it if you've already cycled a standard KSM-66 and want to push potency.
See it on the list →The budget alternative at $14/month — same Ixoreal patent, same 600 mg dose, but no public per-batch COA. The right call if budget is genuinely the constraint and you trust GMP-only QC.
See it on the list →Different patent (Sensoril by Natreon, 10% withanolides root + leaf) at the 125 mg Auddy 2008 clinical dose. The right pick if cortisol / anxiety is the primary endpoint, not testosterone specifically.
See it on the list →600 mg/day KSM-66 for 8 weeks in resistance-trained men measured serum testosterone +96 ng/dL vs +18 placebo, plus strength gains across bench press and leg extension. The key strength + testosterone trial anchoring Double Wood's 600 mg trial-dose protocol.
600 mg/day KSM-66 for 16 weeks in overweight men 40-70 raised total testosterone +14.7% and DHEA-S +18% vs placebo. The cornerstone trial behind the 600 mg dose recommendation for the testosterone endpoint in older / overweight populations.
600 mg/day KSM-66 for 60 days in chronically stressed adults reduced perceived stress -44% and morning serum cortisol -27.9% vs placebo. The headline cortisol-suppression evidence at exactly the Double Wood 600 mg serving dose.
240 mg/day KSM-66 for 60 days lowered morning cortisol -23% and improved sleep quality + DHEA-S +18% vs placebo. Shows the HPA-axis mechanism is sensitive — even at 40% of the Double Wood dose, the cortisol effect lands.
KSM-66 600 mg/day for 8 weeks in healthy adults improved sleep quality scores, reduced anxiety, and lowered morning cortisol. Extends the cortisol/stress evidence from chronically-stressed populations into the broader 'healthy but stressed' demographic that most ashwagandha buyers fall into.
125-250 mg/day Sensoril for 60 days reduced serum cortisol -24.2% and raised DHEA-S +32%. Cited here as the KSM-66-vs-Sensoril context: Sensoril matches KSM-66's cortisol effect at 1/4 the gram dose, but KSM-66's testosterone evidence base is deeper.
